General Information of Drug-Metabolizing Enzyme (DME ID: DME1072)
DME Name Cytochrome P450 MEG (cyp106), Bacillus megaterium DME Info
UniProt ID
CPXM_BACME
EC Number    EC: 1.14.15.8     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
Oxygen paired donor oxidoreductase
Iron-sulfur protein donor oxidoreductase
EC: 1.14.15.8
Lineage    Species: Bacillus megaterium     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Bacillaceae
Genus: Bacillus
Species: Bacillus megaterium
Subspecies: Bacillus megaterium ATCC 13368
Interactome
Interactions between Xenobiotics and DME (XEOTIC)
      Amino Acid(s), Peptide(s) or Protein(s)
                  Peptide Click to Show/Hide the Full List of Xenobiotics:    159 Xenobiotics
                              Anopheles cecropin-A amidated isoform Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02230   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1 microM) [1], [2]
                              Antibacterial napin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02237   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial napin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 215 microM) [3]
                              Antibacterial peptide 3910 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02238   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide 3910 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [4]
                              Antibacterial peptide PMAP-23 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02242   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [5]
                              Antibacterial peptide PMAP-36 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02243   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) [6]
                              Antibacterial peptide PMAP-37 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02244   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 microM) [7]
                              Antibacterial protein PR-39 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02248   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) [8], [9]
                              Antimicrobial peptide AC-AMP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02259   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide AC-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [10], [11]
                              Antimicrobial peptide AC-AMP2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02267   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide AC-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [11]
                              Antimicrobial peptide GP-19 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02282   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [12]
                              Antimicrobial peptide MJ-AMP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02262   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide MJ-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 6 ug/ml) [13], [14]
                              Antimicrobial peptide MJ-AMP2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02269   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide MJ-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 ug/ml) [13], [14]
                              Antimicrobial peptide NK-lysin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02293   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) [15], [16]
                              Antimicrobial protein Ace-AMP1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02299   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Antimicrobial protein Ace-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [17], [18]
                              Apidaecin-1A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02304   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Apidaecin-1A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 150 ug/ml) [19]
                              Apidaecin-1B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02305   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Apidaecin-1B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 100 ug/ml) [19], [20]
                              Apidaecin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02306   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Apidaecin-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 100 ug/ml) [19]
                              Arachnid gomesin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03497   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) [21]
                              Armadillidin glyc-rich Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02319   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Armadillidin glyc-rich inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1.25 microM) [22]
                              Arthropods theromacin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05125   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Arthropods theromacin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [23]
                              Bacteriocin delta-lysin I Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03137   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [24]
                              Bacteriocin HJ50 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02476   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bacteriocin HJ50 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [25], [26]
                              Bombin H7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02468   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bombin H7 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.3 microM) [27]
                              Bombinin-like peptide BLP-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02475   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) [28]
                              Bovine cathelicidin BMAP-34 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02466   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) [29], [30]
                              Brevinin-1E Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02521   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-1E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4 microM) [31], [32]
                              Brevinin-2E Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02584   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Brevinin-2E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) [31]
                              Cathelicidin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02731   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 microM) [33], [34]
                              Cathelicidin-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02739   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [35], [36]
                              Cathelicidin-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02740   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cathelicidin-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 ug/ml) [35], [37]
                              Cecropin-A(1-7)-melittin(1-8) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02756   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) [38]
                              Cecropin-A(1-7)-melittin(2-9) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02757   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.7 microM) [38], [39]
                              Cecropin-A(1-7)-melittin(3-10) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02758   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.9 microM) [38]
                              Cecropin-A(1-7)-melittin(4-11) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02759   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) [38], [40]
                              Cecropin-A(1-7)-melittin(5-12) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02760   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) [38]
                              Cecropin-A(1-7)-melittin(6-13) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02761   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) [38]
                              Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04430   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) [41], [42]
                              Cecropin-A(1-8)-melittin(1-10) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02762   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) [38]
                              Cecropin-A(1-8)-melittin(1-12) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02763   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) [38]
                              Cecropin-A(1-8)-melittin(1-18) hybrid Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02765   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4 microM) [38]
                              Cecropin-D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02771   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 24 microM) [43]
                              Cecropin-P1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02774   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Cecropin-P1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.8 microM) [44], [45]
                              Defensin MGD-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03110   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin MGD-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) [46]
                              Defensin sapecin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04905   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin sapecin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [47], [48]
                              Defensin-like protein sesquin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03119   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Defensin-like protein sesquin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [49]
                              Dermaseptin-like PBN2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03162   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) [50]
                              Dermatoxin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03164   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Dermatoxin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [51]
                              Drosophila cecropin-A1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03224   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1-2.5 microM) [52], [53]
                              Enkelytin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03249   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Enkelytin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) [54], [55]
                              Enterocin AS-48 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03251   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Enterocin AS-48 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [56]
                              Enterocin EJ97 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03254   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Enterocin EJ97 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 ug/ml) [57]
                              Esculentin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03274   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Esculentin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) [31]
                              Esculentin-1B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03277   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Esculentin-1B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) [32]
                              Esculentin-2A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03299   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Esculentin-2A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) [32]
                              Frog bombinin-like peptide BLP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02474   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) [28]
                              Frog phylloxin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04575   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Frog phylloxin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.12 microM) [58]
                              Halocyntin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03522   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Halocyntin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [59]
                              Heligoland antimicrobial peptide A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04762   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) [60]
                              Hevein-like antimicrobial peptide Ee-CBPb Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03243   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hevein-like antimicrobial peptide Ee-CBPb inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [61], [62]
                              Hinnavin I Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03561   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hinnavin I inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [63]
                              Human recombinant Ser-Thr-Ala-CGA1-78 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03605   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Human recombinant Ser-Thr-Ala-CGA1-78 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 30 microM) [64]
                              Hymenoptaecin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03618   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Hymenoptaecin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1 microM) [65]
                              Immune protein P9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02769   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Immune protein P9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.44 microM) [66]
                              Insect attacin-C Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02333   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 200 microM) [67]
                              Insect cecropin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02768   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1-2.5 ug/ml) [68]
                              Insect cecropin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02770   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.64 microM) [43], [69]
                              Insect cecropin-D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02772   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [66], [70]
                              Insect defensin A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03116   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect defensin A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2-2.5 microM) [71]
                              Insect defensin B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03117   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Insect defensin B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2-2.5 microM) [71]
                              KR-12 peptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03712   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation KR-12 peptide inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [72]
                              Lantibiotic lichenicidin VK21 A1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03804   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [73]
                              Lantibiotic lichenicidin VK21 A2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03805   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [73]
                              Lunatusin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03973   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Lunatusin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [74]
                              Mammal mBMAP28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04039   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mammal mBMAP28 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [35]
                              Melittin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04057   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Melittin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.6 microM) [75]
                              Moricin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04128   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Moricin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.09 microM) [76], [77]
                              Myeloid antimicrobial peptide BMAP-27 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04158   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [35]
                              Myeloid antimicrobial peptide BMAP-28 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04159   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [35]
                              Myticin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04166   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myticin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [78]
                              Myticin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04167   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myticin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [78]
                              Myticusin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04168   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Myticusin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5.0 microM) [79]
                              Mytilin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04169   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Mytilin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [80]
                              Napin-like polypeptide Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04235   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Napin-like polypeptide inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [81]
                              Omwaprin-a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04394   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Omwaprin-a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [82], [83]
                              P. americana Pa-AMP-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04424   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P. americana Pa-AMP-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [84], [85]
                              P18 analog N-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04206   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analog N-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04214   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) [41]
                              P18 analog N-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04216   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analog N-3L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04218   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-3L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) [41]
                              P18 analog N-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04219   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analog N-4L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04220   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-4L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) [41]
                              P18 analog N-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04221   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analog N-5L Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04222   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analog N-5L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analogue C-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02663   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analogue C-10 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02664   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-10 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02672   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analogue C-3 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02673   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02674   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-5 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02676   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analogue C-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02677   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-7 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02679   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-7 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-8 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02680   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-8 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue C-9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO02683   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue C-9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              P18 analogue L9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01823   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue L9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) [41]
                              P18 analogue S9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01825   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation P18 analogue S9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [41]
                              Paneth cell-specific alpha-defensin 1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04463   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [86]
                              Papillosin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04468   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Papillosin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [59]
                              Penaeidin-2d Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04506   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) [87], [88]
                              Penaeidin-3a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04507   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) [89]
                              Penaeidin-3a T8A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01827   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.12-6.25 microM) [89]
                              Penaeidin-4a Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04510   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Penaeidin-4a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 50 microM) [87], [90]
                              Penaeidin-4d Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04511   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Penaeidin-4d inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 50 microM) [87], [91]
                              Peptide leucine arginine Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04545   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide leucine arginine inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 20 microM) [92]
                              Peptide PMAP-36(1-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04661   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) [93]
                              Peptide PMAP-36(1-34) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04662   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1 microM) [93]
                              Peptide PMAP-36(1-35)2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04663   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1 microM) [93]
                              Perinerin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04546   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Perinerin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [94]
                              Pig DBI(32-86) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03081   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pig DBI(32-86) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.69 microM) [4], [95]
                              Pilosulin P1(1-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04426   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [96]
                              Plantazolicin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04624   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plantazolicin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [97]
                              Plasticin ANC KF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04625   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plasticin ANC KF inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 12.5 microM) [98]
                              Plasticin PD36 K Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04626   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plasticin PD36 K inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 12.5 microM) [98]
                              Plasticin PD36 KF Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04627   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Plasticin PD36 KF inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 50.25 microM) [98]
                              Ponericin G1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04695   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [99]
                              Ponericin G4 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04697   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ponericin G4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [99]
                              Pore-forming peptide ameobapore A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04707   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 13 microM) [100]
                              Pyrrhocoricin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04770   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Pyrrhocoricin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 80 microM) [101]
                              Ranacyclin-E Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04797   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranacyclin-E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) [102]
                              Ranacyclin-T Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04798   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Ranacyclin-T inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) [102]
                              Recombinant Crassostrea Gigas Defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04840   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 20 microM) [103]
                              Sapecin-C Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04906   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Sapecin-C inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [47]
                              Spheniscin-2 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04971   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4-0.8 microM) [104], [105]
                              Spider gomesin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03498   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) [21]
                              Spinigerin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04974   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Spinigerin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8-1.5 microM) [106], [107]
                              Stomoxyn Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO04995   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78-1.56 microM) [107], [108]
                              Subpeptin JM4-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05004   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Subpeptin JM4-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [109]
                              Subpeptin JM4-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05005   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Subpeptin JM4-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [109]
                              Temporin-1Sa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05063   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Sa inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [110]
                              Temporin-1Sb Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05064   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Sb inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 46 microM) [110]
                              Temporin-1Sc Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05065   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-1Sc inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 ug/ml) [110]
                              Temporin-A Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05076   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2 microM) [111]
                              Temporin-B Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05085   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.8 ug/ml) [111]
                              Temporin-D Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05088   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [111], [112]
                              Temporin-SHa Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05105   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Temporin-SHa inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) [110]
                              Termicin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05110   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Termicin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [106], [113]
                              Thanatin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05120   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) [114], [115]
                              Thanatin truncated isoform Y12M(10-21) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05304   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform Y12M(10-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 20-40 microM) [114]
                              Thanatin truncated isoform G18C(1-18) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03431   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) [114]
                              Thanatin truncated isoform G19Q(1-19) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03432   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform G19Q(1-19) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) [114]
                              Thanatin truncated isoform G20R(1-20) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03435   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) [114]
                              Thanatin truncated isoform I14M(8-21) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03622   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 10-20 microM) [114]
                              Thanatin truncated isoform K18M(4-21) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03681   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) [114]
                              Thanatin truncated isoform V16M(6-21) Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05220   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) [114]
                              Thuricin-17 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05138   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Thuricin-17 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [116]
                              TL(3)[Pro3,DLeu9] Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO01824   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) [117]
                              Type 1 invertebrate defensin Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO03100   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium [118]
                              Vasostatin-1 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05229   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) [64]
                              Venom antimicrobial peptide-6 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05230   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.25 microM) [119]
                              Venom antimicrobial peptide-9 Click to Show/Hide the Detail Inhibition
                                 XEOTIC ID XEO05231   XEOTIC Info Gene Form Protein
                                 Classification Peptide
                                 DME Modulation Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.25 microM) [119]
References
1 Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae. Insect Mol Biol. 2000 Feb;9(1):75-84.
2 Genomic organization and regulation of three cecropin genes in Anopheles gambiae. Insect Mol Biol. 2002 Dec;11(6):517-25.
3 A napin-like polypeptide from dwarf Chinese white cabbage seeds with translation-inhibitory, trypsin-inhibitory, and antibacterial activities. Peptides. 2004 Feb;25(2):171-6.
4 Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. Eur J Biochem. 1993 Sep 1;216(2):623-9.
5 Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J Biol Chem. 1994 Mar 18;269(11):7855-8.
6 Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett. 1994 Jan 17;337(3):303-7.
7 PMAP-37, a novel antibacterial peptide from pig myeloid cellscDNA cloning, chemical synthesis and activity. Eur J Biochem. 1995 Mar 15;228(3):941-6.
8 Amino acid sequence of PR-39Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem. 1991 Dec 18;202(3):849-54.
9 Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7085-9.
10 Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycine-rich domain of chitin-binding proteins. Biochemistry. 1992 May 5;31(17):4308-14.
11 Location of the three disulfide bonds in an antimicrobial peptide from Amaranthus caudatus using mass spectrometry. J Pept Res. 1997 Apr;49(4):336-40.
12 Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10. Peptides. 2012 Jun;35(2):253-60.
13 Isolation and characterization of a novel class of plant antimicrobial peptides form Mirabilis jalapa Lseeds. J Biol Chem. 1992 Feb 5;267(4):2228-33.
14 Cloning and characterization of two cDNA clones encoding seed-specific antimicrobial peptides from Mirabilis jalapa L. Plant Mol Biol. 1995 Jul;28(4):713-21.
15 NK-lysin, a novel effector peptide of cytotoxic T and NK cellsStructure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 1995 Apr 18;14(8):1615-25.
16 Saposin fold revealed by the NMR structure of NK-lysin. Nat Struct Biol. 1997 Oct;4(10):793-5.
17 A potent antimicrobial protein from onion seeds showing sequence homology to plant lipid transfer proteins. Plant Physiol. 1995 Oct;109(2):445-55.
18 Solution structure of Ace-AMP1, a potent antimicrobial protein extracted from onion seedsStructural analogies with plant nonspecific lipid transfer proteins. Biochemistry. 1998 Mar 17;37(11):3623-37.
19 Apidaecins: antibacterial peptides from honeybees. EMBO J. 1989 Aug;8(8):2387-91.
20 Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera). Eur J Biochem. 1990 Jan 26;187(2):381-6.
21 Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem. 2000 Oct 27;275(43):33464-70.
22 Armadillidin: a novel glycine-rich antibacterial peptide directed against gram-positive bacteria in the woodlouse Armadillidium vulgare (Terrestrial Isopod, Crustacean). Dev Comp Immunol. 2005;29(6):489-99.
23 Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities. J Biol Chem. 2012 Apr 20;287(17):14246-58.
24 Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri. Peptides. 2008 Jun;29(6):978-84.
25 Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. Microbiology. 2004 Jan;150(Pt 1):103-108.
26 Characteristics of the bovicin HJ50 gene cluster in Streptococcus bovis HJ50. Microbiology. 2009 Feb;155(Pt 2):584-593.
27 Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers. 1998;47(6):435-50.
28 Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J Biol Chem. 1991 Dec 5;266(34):23103-11.
29 Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett. 1997 Nov 17;417(3):311-5.
30 Biological characterization of a novel mammalian antimicrobial peptide. Biochim Biophys Acta. 1998 Oct 23;1425(2):361-8.
31 Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. FEBS Lett. 1993 Jun 14;324(2):159-61.
32 Antimicrobial peptides from skin secretions of Rana esculentaMolecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J Biol Chem. 1994 Apr 22;269(16):11956-61.
33 Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem. 1997 May 16;272(20):13088-93.
34 A novel murine cathelin-like protein expressed in bone marrow. FEBS Lett. 1996 Aug 5;391(1-2):5-8.
35 Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem. 1996 Nov 8;271(45):28375-81.
36 Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. Eur J Biochem. 1996 Jun 15;238(3):769-76.
37 Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family. J Hered. 2009 Mar-Apr;100(2):241-5.
38 Shortened cecropin A-melittin hybridsSignificant size reduction retains potent antibiotic activity. FEBS Lett. 1992 Jan 20;296(2):190-4.
39 Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves. J Am Chem Soc. 2007 Apr 25;129(16):5228-34.
40 Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides. Curr Microbiol. 2010 Sep;61(3):169-75.
41 Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. J Pept Res. 2001 Dec;58(6):504-14.
42 Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18. Protein Pept Lett. 2002 Oct;9(5):395-402.
43 Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi. Eur J Biochem. 1982 Sep;127(1):219-24.
44 Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum. Biochem J. 2005 Aug 15;390(Pt 1):207-14.
45 The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur J Biochem. 1992 Oct 1;209(1):163-9.
46 Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1). Biochemistry. 2000 Nov 28;39(47):14436-47.
47 Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin. Biochem J. 1993 Apr 1;291 ( Pt 1):275-9.
48 Molecular cloning of cDNA for sapecin B, an antibacterial protein of Sarcophaga, and its detection in larval brain. FEBS Lett. 1995 Jul 24;368(3):485-7.
49 Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptides. 2005 Jul;26(7):1120-6.
50 Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. Eur J Biochem. 2003 May;270(9):2068-81.
51 Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family. Eur J Biochem. 2000 Jul;267(14):4583-92.
52 Molecular evolution of the Cecropin multigene family in Drosophilafunctional genes vspseudogenes. Genetics. 1998 Sep;150(1):157-71.
53 Evolutionary history and mechanism of the Drosophila cecropin gene family. Immunogenetics. 1998 May;47(6):417-29.
54 Partial characterization of the mRNA that codes for enkephalins in bovine adrenal medulla and human pheochromocytoma. Proc Natl Acad Sci U S A. 1982 Jan;79(2):360-4.
55 The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem. 1996 Feb 1;235(3):516-25.
56 Structure of bacteriocin AS-48: from soluble state to membrane bound state. J Mol Biol. 2003 Nov 28;334(3):541-9.
57 Structural characterisation of the natively unfolded enterocin EJ97. Protein Eng Des Sel. 2010 Jul;23(7):507-18.
58 Phylloxin, a novel peptide antibiotic of the dermaseptin family of antimicrobial/opioid peptide precursors. Eur J Biochem. 2000 Jan;267(2):370-8.
59 Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa. J Pept Sci. 2009 Jan;15(1):48-55.
60 A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity. Dev Comp Immunol. 2008;32(3):286-98.
61 Synergistic antifungal activity of two chitin-binding proteins from spindle tree (Euonymus europaeus L.). Planta. 2004 Jun;219(2):221-32.
62 Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.). FEBS Lett. 2002 Oct 23;530(1-3):181-5.
63 Hinnavin I, an antibacterial peptide from cabbage butterfly, Artogeia rapae. Mol Cells. 1997 Aug 31;7(4):509-13.
64 Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem. 2000 Apr 14;275(15):10745-53.
65 Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera). J Biol Chem. 1993 Apr 5;268(10):7044-54.
66 Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur J Biochem. 1982 Sep;127(1):207-17.
67 Primary structure and in vitro antibacterial properties of the Drosophila melanogaster attacin C Pro-domain. J Biol Chem. 2004 Apr 9;279(15):14853-9.
68 Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti. J Biol Chem. 1999 Jul 16;274(29):20092-7.
69 Plasma desorption mass spectrometry coupled with conventional peptide sequencing techniques. Biomed Environ Mass Spectrom. 1987 Nov;14(11):669-73.
70 The cecropin locusCloning and expression of a gene cluster encoding three antibacterial peptides in Hyalophora cecropia. J Biol Chem. 1991 Jun 25;266(18):11510-7.
71 Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity. Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.
72 Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem. 2008 Nov 21;283(47):32637-43.
73 Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry. 2010 Aug 3;49(30):6462-72.
74 Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.). Peptides. 2005 Nov;26(11):2086-92.
75 Identification of a novel melittin isoform from Africanized Apis mellifera venom. Peptides. 2010 Aug;31(8):1473-9.
76 Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori. J Biol Chem. 1995 Dec 15;270(50):29923-7.
77 Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori. FEBS Lett. 2002 May 8;518(1-3):33-8.
78 Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis. Eur J Biochem. 1999 Oct 1;265(1):71-8.
79 Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus. Fish Shellfish Immunol. 2013 Feb;34(2):610-6.
80 Innate immunityIsolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J Biol Chem. 1996 Sep 6;271(36):21808-13.
81 A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds. J Pept Res. 2004 Nov;64(5):202-8.
82 Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem J. 2007 Feb 15;402(1):93-104.
83 Determination of the X-ray structure of the snake venom protein omwaprin by total chemical synthesis and racemic protein crystallography. Protein Sci. 2010 Oct;19(10):1840-9.
84 Purification, characterization, and molecular cloning of the gene of a seed-specific antimicrobial protein from pokeweed. Plant Physiol. 2000 Apr;122(4):1015-24.
85 Solution structure of PAFP-S: a new knottin-type antifungal peptide from the seeds of Phytolacca americana. Biochemistry. 2001 Sep 18;40(37):10973-8.
86 A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function. Biochem J. 2007 Oct 15;407(2):267-76.
87 Diversity of the penaeidin antimicrobial peptides in two shrimp species. Immunogenetics. 2002 Sep;54(6):442-5.
88 Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp. Eur J Biochem. 1999 Dec;266(2):335-46.
89 Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide. J Biol Chem. 2003 Sep 19;278(38):36859-67.
90 A new class (penaeidin class 4) of antimicrobial peptides from the Atlantic white shrimp (Litopenaeus setiferus) exhibits target specificity and an independent proline-rich-domain function. Biochem J. 2004 Jul 1;381(Pt 1):79-86.
91 Solution structure of synthetic penaeidin-4 with structural and functional comparisons with penaeidin-3. J Biol Chem. 2005 Apr 22;280(16):16009-18.
92 Peptide leucine arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin of the Northern Leopard frog, Rana pipiens. J Biol Chem. 2001 Mar 30;276(13):10145-52.
93 Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J. 2005 Sep;272(17):4398-406.
94 Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. J Biochem. 2004 Mar;135(3):297-304.
95 Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem. 1988 Jun 1;174(2):239-45.
96 Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.
97 Plantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42. J Bacteriol. 2011 Jan;193(1):215-24.
98 The plasticins: membrane adsorption, lipid disorders, and biological activity. Biochemistry. 2006 Dec 5;45(48):14285-97.
99 Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. J Biol Chem. 2001 May 25;276(21):17823-9.
100 Solution structure of the pore-forming protein of Entamoeba histolytica. J Biol Chem. 2004 Apr 23;279(17):17834-41.
101 Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK. J Mol Biol. 2013 Jul 24;425(14):2463-79.
102 Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry. 2003 Dec 2;42(47):14023-35.
103 Characterization of a defensin from the oyster Crassostrea gigasRecombinant production, folding, solution structure, antimicrobial activities, and gene expression. J Biol Chem. 2006 Jan 6;281(1):313-23.
104 Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus. J Biol Chem. 2003 Dec 19;278(51):51053-8.
105 Solution structure of spheniscin, a beta-defensin from the penguin stomach. J Biol Chem. 2004 Jul 16;279(29):30433-9.
106 Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect. J Biol Chem. 2001 Feb 9;276(6):4085-92.
107 Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation. Biopolymers. 2006 Feb 5;81(2):92-103.
108 Epithelial innate immunityA novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans. J Biol Chem. 2002 Dec 20;277(51):49921-6.
109 Purification and characterization of two novel antimicrobial peptides Subpeptin JM4-A and Subpeptin JM4-B produced by Bacillus subtilis JM4. Curr Microbiol. 2005 Nov;51(5):292-6.
110 Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica. Peptides. 2008 Sep;29(9):1526-33.
111 Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem. 1996 Dec 15;242(3):788-92.
112 Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem. 2000 Mar;267(5):1447-54.
113 Solution structure of termicin, an antimicrobial peptide from the termite Pseudacanthotermes spiniger. Protein Sci. 2003 Mar;12(3):438-46.
114 Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-5.
115 Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur J Biochem. 1998 Sep 1;256(2):404-10.
116 The 3D solution structure of thurincin H, a bacteriocin with four sulfur to alpha-carbon crosslinks. Angew Chem Int Ed Engl. 2011 Sep 5;50(37):8718-21.
117 Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: evaluation of antimicrobial, cytotoxic and hemolytic activities. Eur J Med Chem. 2017 Oct 20;139:750-761.
118 Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochem J. 1994 Jun 1;300 ( Pt 2):567-75.
119 Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. FASEB J. 2009 Apr;23(4):1230-45.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.